miR-124 acts as a tumor suppressor in breast cancer by directly targeting and inhibiting FLOT1, reducing cell proliferation and migration.
No takes yet. Share an insight, caveat, or question.
May support miR-124 as tumor suppressor biomarker in breast cancer; leaves open therapeutic applications pending clinical validation.
Li et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: